Diabetic gastroparesis: Functional/morphologic background, diagnosis, and treatment options

Current Diabetes Reports

Volumn 14, Issue 9, 2014, Pages

  Horváth, Viktor J ^a   Izbéki, Ferenc ^b   Lengyel, Csaba ^c   Kempler, Péter ^a   Várkonyi, Tamás ^c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Szent Gyorgy Hospital of Fejer County   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Diabetes mellitus; Diabetic gastroparesis; Gastroparesis; Interstitial cells of Cajal; Neural elements

Indexed keywords

APREPITANT; AZITHROMYCIN; DOMPERIDONE; ERYTHROMYCIN; HORMONE; METOCLOPRAMIDE; NITRIC OXIDE SYNTHASE;

ACUPUNCTURE; AUTONOMIC NEUROPATHY; BOTULINUM TOXIN INJECTION; CELL FUNCTION; DIABETES MELLITUS; DIABETIC GASTROPARESIS; ECHOGRAPHY; ENZYME ACTIVITY; GASTRIC DYSMOTILITY; GASTRIC ELECTRICAL NEUROSTIMULATION; GASTRIC ELECTRICAL PACING; GLIA CELL; HORMONE ACTION; HUMAN; INJECTION; JEJUNOSTOMY; NERVE STIMULATION; NONHUMAN; PATHOGENESIS; PERCUTANEOUS ENDOSCOPIC JEJUNOSTOMY; REVIEW; STOMACH EMPTYING; STOMACH MOTILITY; STOMACH PARESIS; SUDDEN DEATH; TRANSPORT AT THE CELLULAR LEVEL; ANIMAL; DIABETES COMPLICATIONS; GASTROPARESIS; GLIA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; DIABETES COMPLICATIONS; GASTRIC EMPTYING; GASTROPARESIS; HUMANS; NEUROGLIA; NITRIC OXIDE SYNTHASE;

EID: 84903807617     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-014-0527-8     Document Type: Review

References (99)

1. Collins PJ et al. Role of the proximal and distal stomach in mixed solid and liquid meal emptying. Gut. 1991;32:615-9.
2. O'Grady G et al. Origin and propagation of human gastric slow-wave activity defined by high-resolution mapping. Am J Physiol Gastrointest Liver Physiol. 2010;299(3):585-2.
3. Wood JD. Neurogastroenterology and motility. In: Rhoades RA, Bell DR, editors. Principles of medical phisiology. 3rd edn. LWW; 2009. pp. 483-6.
4. Kashyap P et al. Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut. 2010;59:1716-26.
5. Rundles RW. Diabetic neuropathy: general review with report of 125 cases. Medicine. 1945;24:111-60.
6. Soykan I et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998;43:2398-404. (Pubitemid 28531310)
7. Feldman M et al. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med. 1983;98:378-84. (Pubitemid 13158511)
8. CamilleriM. Clinical practice. Diabetic gastroparesis. N Engl JMed. 2007;356:820-9.
9. Jones KL et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care. 2001;24:1264-9. (Pubitemid 33716409)
10. Barucha AE et al. Relationship between clinical features and gastric emptying disturbances in diabetes mellitus. Clin Endocrinol (Oxf). 2009;70(3):415-20.
11. Ebert EC. Gastrointestinal complications of diabetes mellitus. Dis Mon. 2005;51(12):620-63. (Pubitemid 43183740)
12. Nowak TV et al. Highly variable gastric emptying in patients with insulin dependent diabetes mellitus. Gut. 1995;37:23-9.
13. Kong MF et al. Natural history of diabetic gastroparesis. Diabetes Care. 1999;22:503-7.
14. Revicki DA et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther. 2003;18:141-50. (Pubitemid 36897991)
15. De la Loge C et al. Cross-cultural development and validation of a self-administered questionnaire to assess quality of life in upper gastrointestinal disorders. Qual Life Res. 2004;13:1751-62.
16. Bytzer P et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus. Arch Intern Med. 2001;161:1989-96.
17. Hasler WL. Type 1 diabetes and gastroparesis: diagnosis and treatment. Curr Gastroenterol Rep. 2007;9:261-9. (Pubitemid 47489985)
18. Ordog T. Interstitial cells of Cajal in diabetic gastroenteropathy. Neurogastroenterol Motil. 2008;20:8-18. (Pubitemid 350277445)
19. Intagliata N et al. Gastroparesis in type 2 diabetes mellitus: prevalence, etiology, diagnosis, and treatment. Curr Gastroenterol Rep. 2007;9:270-9. (Pubitemid 47489986)
20. Watkins CC et al. Insulin restores neuronal nitric oxide synthase expression and function that lost in diabetic gastropathy. J Clin Invest. 2000;106(3):373-84. (Pubitemid 30655637)
21. Ordog T et al. Cellular pathogenesis of diabetic gastroenteropathy. Minerva Gastroenterol Dietol. 2009;55(3):315-43.
22. KongMF et al. Gastric emptying in diabetes mellitus: relationship to blood-glucose control. Clin Geriatr Med. 1999;15:321-38.
23. Koch KL et al. Diabetic gastroparesis: comparison of clinical features in patients with Type 2 (T2DM) and Type 1 (T1DM) diabetesmellitus [abstract]. Am J Gastroenterol. 2009;104(Suppl3):S56.
24. Izbéki F et al. The clinical picture, diagnosis and therapy of gastrointestinal autonomic neuropathy. In: Kempler P, Várkonyi T, editors. Neuropathies. A global clinical guide. Budapest: Zafír Press - Mona Lib Kft; 2012. p. 131-50.
25. MacGregor IL et al. The effect of acute hyperglycemia on gastric emptying in man. Gastroenterology. 1976;70:190-6.
26. Jebbink RJ et al. Hyperglycaemia induces abnormalities of gastric myoelectrical activity in patients with type I diabetes mellitus. Gastroenterology. 1994;107(5):1994-9.
27. Horváth VJ et al. Reduced insulin and IGF-I signaling, not hyperglycemia, underlies the diabetes-associated depletion of interstitial Cells of cajal in the murine stomach. Diabetes. 2005;54:1528-33. (Pubitemid 40586686)
28. Schvarcz E et al. Physiological hyperglycaemia slows gastric emptying in normal subjects and in patients with insulin-dependent diabetes mellitus. Gastroenterology. 1997;113(1):60-6. (Pubitemid 27281758)
29. Vittal H et al. Mechanisms of disease: the pathological basis of gastroparesis-a review of experimental and clinical studies. Nat Clin Pract Gastroenterol Hepatol. 2007;4(6):336-46. (Pubitemid 47393759)
30. Camilleri M et al. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology. 1986;91:94-9. (Pubitemid 16086660)
31. Hirst GD et al. Electrical events underlying organized myogenic contractions of the guinea pig stomach. J Physiol. 2006;576:659-65. (Pubitemid 44637870)
32. Parkman HP et al.American gastroenterological association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1592-622. (Pubitemid 39457783)
33. Nishikawa Tet al. Normalizingmitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787-90.
34. Choi KM et al. Differences in protein expression between diabetic NOD mice with and without delayed gastric emptying. Gastroenterology. 2007;132:A-112.
35. Choi KM et al. Regulation of interstitial cells of Cajal in the mouse gastric body by neuronal nitric oxide. Neurogastroenterol Motil. 2007;19:585-95. (Pubitemid 46985596)
36. Harberson J et al. Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies. Dig Dis Sci. 2010;10:359-70.
37. Grover M et al. Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium. Neurogastroenterol Motil. 2012;24(6):531-40.
38. Selim MM et al. Gastric mucosal nerve density: a biomarker for diabetic autonom neuropathy? Neurology. 2010;75(11):973-81.
39. Gover M, NIDDK Gastroparesis Clinical Research Consortium, et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology. 2011;140(5):1575-85.
40. Horváth VJ et al. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of Cajal in murine diabetic gastroparesis. Gastroenterology. 2006;130(3):759-70. (Pubitemid 43374526)
41. Wu JJ et al. Development of the interstitial cell of Cajal: origin, kit dependence and neuronal and nonneuronal sources of kit ligand. J Neurosci Res. 2000;59(3):384-401. (Pubitemid 30107979)
42. Lorincz A et al. Progenitors of interstitial cells of Cajal in the postnatal murine stomach. Gastroenterology. 2008;134(4):1083-93. (Pubitemid 351451982)
43. Izbeki F et al. Loss of Kitlow progenitors, reduced stem cell factor and high oxidative stress underlie gastric dysfunction in progeric mice. J Physiol. 2010;588(16):3101-7.
44. Kempler P et al. On behalf of the Toronto Consensus Panel on Diabetic Neuropathy Gastrointestinal autonomic neuropathy, erectile-, bladder- and sudomotor dysfunction in patients with diabetes mellitus: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011;27:665-77.
45. Oh JHet al. Recent advances in the pathophysiology and treatment of gastroparesis. J Neurogastroenterol Motil. 2013;19(1):18-24.
46. HaslerWL. Gastroparesis: pathogenesis, diagnosis and management. Nat Rev Gastroenterol Hepatol. 2011;8(8):438-53.
47. Bolinder J et al. Autonomic neuropathy is associated with impaired pancreatic polypeptide and neuropeptide Y responses to insulin-induced hypoglycaemia in Type I diabetic patients. Diabetologia. 2002;45(7):1043-4. (Pubitemid 34762203)
48. Kempler P, EURODIAB IDDM Complications Study Group, et al. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabet Med. 2002;19(11):900-9. (Pubitemid 35356915)
49. Chang J et al. A 25-year longitudinal evaluation of gastric emptying in diabetes. Diabetes Care. 2012;35(12):2594-6.
50. Lam WF et al. Hyperglycemia reduces gastric secretory and plasma pancreatic polypeptide responses to modified sham feeding in humans. Digestion. 1993;54:48-53. (Pubitemid 23145770)
51. Yeap BB et al. Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects. Diabetes Care. 1996;19(8):880-2. (Pubitemid 26286996)
52. Várkonyi T et al. Manifestations of diabetic polyneuropathy in the digestive tract and the central nervous system. Diabetol Hung. 2002;10 suppl 2:44-50.
53. Pavy-Le Traon A et al. Cardiovascular autonomic neuropathy and other complications in type 1 diabetes. Clin Auton Res. 2010;20(3):153-60.
54. Lelic D et al. The brain networks encoding visceral sensation in patients with gastrointestinal symptoms due to diabetic neuropathy. Neurogastroenterol Motil. 2014;26(1):46-58.
55. Brock C et al. Peripheral and central nervous contribution to gastrointestinal symptoms in diabetic patients with autonomic neuropathy. Eur J Pain. 2012;17:820-31.
56. Várkonyi T et al. Severity of autonomic and sensory neuropathy and the impairment of visual- and auditory-evoked potentials in type 1 diabetes. Is there a relationship? Diabetes Care. 2006;29:2325-6. (Pubitemid 44899875)
57. Punkkinen J et al. Upper abdominal symptoms in patients with Type 1 diabetes: unrelated to impairment in gastric emptying caused by autonomic neuropathy. Diabet Med. 2008;25(5):570-7. (Pubitemid 351590890)
58. Søfteland E et al. Association between visceral, cardiac and sensorimotor polyneuropathies in diabetes mellitus. J Diabetes Complicat. 2013. doi:10.1016/j.jdiacomp.2013.10.009.
59. Chang J et al. Diabetic gastroparesis-backwards and forwards. J Gastroenterol Hepatol. 2011;26 Suppl 1:46-57.
60. Konturek JW et al. Effects of nitric oxide on antral motility and gastric emptying in humans. Eur J Gastroenterol Hepatol. 1995;7(2):97-102.
61. ManerWL et al.Diabetes induces sex-dependent changes in neuronal nitric oxide synthase dimerization and function in the rat gastric antrum. Am J Physiol Gastrointest Liver Physiol. 2007;292:725-33.
62. Micci MA et al. Neural stem cell transplantation in the stomach rescues gastric function in neuronal nitric oxide synthase-deficient mice. Gastroenterology. 2005;129(6):1817-24. (Pubitemid 41772960)
63. Pala L et al. Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions. Diabet Med. 2010;27(6):691-5.
64. Ariga H et al. Ghrelin accelerates gastric emptying via early manifestation of antro-pyloric coordination in conscious rats. Regul Pept. 2008;146(1-3):112-6.
65. Falkén Yet al. Actions of prolonged ghrelin infusion on gastrointestinal transit and glucose homeostasis in humans. Neurogastroenterol Motil. 2010;22(6):192-200.
66. Kojima M et al. Ghrelin: structure and function. Physiol Rev. 2005;85(2):495-522. (Pubitemid 40404635)
67. Gaddipati KV et al. Abnormal ghrelin and pancreatic polypeptides responses in gastroparesis. Dig Dis Sci. 2006;51(8):1339-46. (Pubitemid 44315799)
68. Kan M et al. Glucagon-like peptide 1, insulin, sensory neurons, and diabetic neuropathy. J Neuropathol Exp Neurol. 2012;71(6):494-510.
69. SamAHet al. Selective ablation of peptideYYcells in adultmice reveals their role in beta cell survival. Gastroenterology. 2012;143(2):459-69.
70. Rühl A. Glial cells in the gut. Neurogastroenterol Motil. 2005;17:777-9.
71. Nezami BG. Enteric nervous system in the small intestine: pathophysiology and clinical implications. Curr Gastroenterol Rep. 2010;12:358-5.
72. Aubé AC et al. Changes in enteric neurone phenotype and intestinal functions in a transgenic mouse model of enteric glia disruption. Gut. 2006;55(5):630-7.
73. Abdo H et al. Enteric glial cells protect neurons from oxidative stress in part via reduced glutathione. FASEB J. 2010;24(4):1082-94.
74. Chandrasekharan B et al. Diabetes and the enteric nervous system. Neurogastroenterol Motil. 2007;19(12):951-60. (Pubitemid 350198313)
75. Abell TL et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol. 2008;36:44-54. (Pubitemid 351520592)
76. Gilja OH. Ultrasound of the stomach - the EUROSON lecture 2006. Ultraschall Med. 2007;28:32-9. (Pubitemid 46696973)
77. Marzio L et al. Evaluation of the use of ultrasonography in the study of liquid gastric emptying. Am J Gastroenterol. 1989;84:496-500. (Pubitemid 19143067)
78. Stevens JE et al. Measurement of gastric emptying of a high-nutrient liquid by 3D ultrasonography in diabetic gastroparesis. Neurogastroenterol Motil. 2011;23:220-5.
79. Olausson EAet al. Small particle size of a solidmeal increases gastric emptying and late postprandial glycaemic response in diabetic subjects with gastroparesis. Diabetes Res Clin Pract. 2008;80:231-7.
80. Perkel MS et al. Metoclopramide therapy in patients with delayed gastric emptying: a randomized, double-blind study. Dig Dis Sci. 1979;24:662-6. (Pubitemid 10223133)
81. Van Thiel DH. Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis. Dig Dis Sci. 1985;30:10-5.
82. Ricci DA et al. Effect of metoclopramide in diabetic gastroparesis. J Clin Gastroenterol. 1985;7:25-32. (Pubitemid 15126539)
83. Henry P et al. Clinical response and side effects of metoclopramide associations with clinical, demographic, and pharmacogenetic parameters. J Clin Gastroenterol. 2012;46:494-503.
84. Strauss SM et al. Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J. 2005;26:2007-12.
85. Lin HC et al. Erythromycin accelerates solid emptying at the expense of gastric sieving. Dig Dis Sci. 1994;39:124-8. (Pubitemid 24041719)
86. Moshiree B et al. Comparison of the effect of azithromycin versus erythromycin on antroduodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesis. Dig Dis Sci. 2010;55(3):675-83.
87. Ray WA et al. Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med. 2004;351:1089-96.
88. Várkonyi T et al. Diabetic neuropathy: new strategies for treatment. Diabetes Obes Metab. 2008;10:99-108.
89. Ziegler D et al. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care. 1997;20(3):369-73. (Pubitemid 27098226)
90. Várkonyi Tet al. Current options and perspectives in the treatment of diabetic neuropathy. Curr Pharm Des. 2013;19(27):4981-5007.
91. Wo JM et al. Randomised clinical trial: ghrelin agonist TZP101 relieves gastroparesis associated with severe nausea and vomiting - randomised clinical study subset data. Aliment Pharmacol Ther. 2011;33:679-88.
92. Camilleri M et al. A ghrelin agonist fails to show benefit in patients with diabetic gastroparesis: let's not throw the baby out with the bath water. Neurogastroenterol Motil. 2013;25(11):859-63.
93. Chong K et al. A case of severe, refractory diabetic gastroparesis managed by prolonged use of aprepitant. Nat Rev Endocrinol. 2009;5:285-8.
94. Abell T et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology. 2003;125(2):421-8. (Pubitemid 36929423)
95. Kim KH et al. Acupuncture for symptomatic relief of gastroparesis in a diabetic haemodialysis patient. Acupunct Med. 2010;28:101-3.
96. Lin Z et al. Association between changes in symptoms and gastric emptying in gastroparetic patients treated with gastric electrical stimulation. Neurogastroenterol Motil. 2008;20:464-70. (Pubitemid 351548632)
97. Abell TL et al. Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion. 2002;66:204-12. (Pubitemid 36578770)
98. McCallum RW et al. Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology. 1998;114:456-61.
99. Fontana RJ et al. Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review. Am J Gastroenterol. 1996;91:2174-8. (Pubitemid 26338974)